News Posts List
Kidney Cancer Discovery Could Expand Treatment Options
06/02/2011
Oregon Health & Science University Knight Cancer Institute researchers uncovered a gene that may be the key to helping kidney cancer patients who don't respond to current therapies.
USA Today: Kidney Health Report
05/31/2011
Mediaplanet Publishing released a Kidney Health report to targeted markets in USA Today. The report is distributed to 1 million readers with contributions from Kidney Cancer Association, National Kidney Foundation, Fresenius Medical Care North America, UKidney, Medical Education Institute, and National Kidney Registry.
Active surveillance may be viable option for small renal masses
05/25/2011
Active surveillance may be a viable short-term treatment option in select patients with small renal masses, researchers from Fox Chase Cancer Center, Philadelphia.
VIDEOS: National Patient Conference
05/24/2011
Learn about state-of-the art treatment of kidney cancer from world-renown experts.
Obama Budget Caps Donations to Charity
05/23/2011
Independent Sector urges Congress to reject proposals to limit the value of itemized deductions for charitable donations. As nonprofit organizations struggle to meet increased demand for services and raise the necessary funds to meet those needs, Congress should seek to encourage all individuals, regardless of income and wealth, to give more to charitable organizations.
Patients Abandoned Oral Anti-Cancer Drugs
05/19/2011
High Cost-Sharing and Higher Concurrent Prescription Activity Are Key Factors Related to Abandonment of Medicines
Nexavar Data to Be Presented
05/19/2011
Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq:ONXX - News) today announced that data evaluating the use of Nexavar® (sorafenib) tablets will be presented in a scientific forum at the 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO), June 3-7, in Chicago.
Pfizer kidney cancer drug effective in key study
05/19/2011
Company expected to seek U.S. approval this year
Lymphocyte Count Indicates Prognosis of Patients With Renal Cell Carcinoma
05/19/2011
Now, researchers at Fox Chase Cancer Center have discovered that the lymphocyte count--which is routinely measured in laboratory tests--is a simple and effective prognostic indicator in patients with renal cell carcinoma (RCC).
News Feed